"Official medicines" is the best online drugstore.

World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system.

The meds you need, reliable and hassle free! Top products of top brands.

The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe!


(NYE-CAR-dih-peen HIGH-droe-KLOR-ide)
Cardene
Capsules: 20 mg, 30 mg
Cardene I.V.
Injection: 2.5 mg/mL
Cardene SR
Capsules, sustained-release: 30 mg, 45 mg, 60 mg
Class: Calcium channel blocker

 Action Inhibits movement of calcium ions across cell membrane in systemic and coronary vascular smooth muscle and myocardium.

 Indications Treatment of chronic stable (effort-associated) angina (immediate-release capsules); management of hypertension (immediate- and sustained-release capsules; IV when oral therapy not feasible or desireable).

 Contraindications Sick sinus syndrome; second- or third-degree atrioventricular (AV) block except with functioning pacemaker; advanced aortic stenosis.

 Route/Dosage

Angina (Immediate-Release Only)

ADULTS: PO Usual initial dose 20 mg tid (range, 20 to 40 mg tid).

Hypertension

ADULTS: PO Immediate-release: Usual dose 20 mg tid (range, 20 to 40 mg tid). Sustained-release: Start with 30 mg bid (range, 30 to 60 mg bid). IV Individualize dosage based on severity of hypertension and response of patient during dosing.

 Interactions

Cyclosporine: May cause increased cyclosporine levels with possible toxicity. Other hypertensive agents: May have additive effects.

 Lab Test Interferences None well documented.

 Adverse Reactions

CV: Peripheral edema; palpitations; AV block; MI; angina; tachycardia; abnormal ECG. CNS: Dizziness; lightheadedness; asthenia; psychiatric disturbances; headache; paresthesia; somnolence; weakness. DERM: Rash. GI: Nausea; abdominal discomfort; cramps; dyspepsia; dry mouth; thirst. OTHER: Flushing; allergic reaction; myalgia.

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy not established. Antiplatelet effects: Calcium channel blockers may inhibit platelet function. Beta-blocker withdrawal: Patients withdrawn from beta-blockers while taking nicardipine may experience increased angina. Gradually taper beta-blocker dose. CHF: Use drug with caution in patients with CHF. Hepatic impairment: Adjust dosage and use drug with caution in patients with impaired hepatic function or reduced hepatic blood flow. Increased angina: Occasionally patients have increased frequency, duration, or severity of angina on starting or increasing dose. Renal impairment: Adjust dose in patients with renal dysfunction. Withdrawal: Abrupt withdrawal may cause increased frequency and duration of angina.

PATIENT CARE CONSIDERATIONS

 Administration/Storage

  • Administer without regard to meals. Avoid giving with high-fat meals.
  • If patient is taking sustained-released capsules, instruct patient to swallow capsule whole and not to chew, divide, or crush.
  • If stopping medication, taper dose slowly. Stopping drug quickly could result in immediate angina.
  • If patient has history of liver or renal disease, start with low doses and titrate.
  • Do not increase dose for minimum of 3 days after starting medication or dose changes.
  • When converting from immediate-release form to sustained-release form, note that dosage may differ.
  • Store at controlled room temperature (56° to 86°F) in tight, light-resistant container.

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Evaluate cardiac, hepatic, renal, and thyroid function.
  • Obtain baseline vital signs and monitor 1 to 2 hr and 8 hr after administration of immediate-release product and 2 to 4 hr and at end of dosing interval if sustained-release product is used.
  • Obtain baseline ECG and any follow-up ECGs as ordered by health care provider.
  • Assess for edema, dizziness, headache, sore throat, renal changes, palpitations, liver dysfunction, or flushing.
  • If patient has history of liver, renal, or cardiac dysfunction, monitor patient closely for changes from baseline.
  • If there are any changes from baseline assessment, notify health care provider.
  • If used to treat angina, monitor frequency of anginal episodes and consumption of sublingual nitroglycerin.
OVERDOSAGE: SIGNS & SYMPTOMS
  Nausea, weakness, dizziness, drowsiness, confusion, slurred speech, marked and prolonged hypotension, bradycardia, functional rhythms, second- or third-degree AV block, palpitations, flushing, nervousness, vomiting

 Patient/Family Education

  • Instruct patient to swallow sustained-release capsules whole and not to crush or chew.
  • Caution patient that increased angina may occur initially when starting, changing dose, or stopping medication.
  • Advise patient not to stop taking drug abruptly.
  • Instruct patient to report the following symptoms to health care provider: any unusual bleeding, bruising, rash, palpitations, irregular heartbeat, shortness of breath, nausea, change in angina, constipation, changes in gums, dizziness, or swelling in hands or feet.
  • Advise patient that drug may cause dizziness or drowsiness and to use caution while driving or performing other tasks requiring mental alertness.

Popularity: 1% [?]


If you're still unable to find appropriate information in the article, please use search form below